BusinessCrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research ProgramsBy Nasdaq OMXNov 21, 2017, 1:00 PM UTC
BusinessNewLink Genetics Announces the Presentation of Indoximod Data in Phase 1 Study for ChildrenBy Nasdaq OMXNov 20, 2017, 9:25 PM UTC
BusinessPremier Biomedical’s CEO, William A. Hartman, Returns to Uptick Network “Stock Day” for an Update on Latest Company DevelopmentsBy Nasdaq OMXNov 20, 2017, 1:01 PM UTC
BusinessDeciphera Pharmaceuticals Reports Data from Ongoing Phase 1 Clinical Study of DCC-2618 at the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-OncologyBy Nasdaq OMXNov 20, 2017, 12:00 PM UTC
BusinessCrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology ResearchBy Nasdaq OMXNov 17, 2017, 4:53 PM UTC
BusinessSentia Medical Sciences Inc. Announces the Launch of a New Initiative in Stress-related Disorders Targeting Gastrointestinal and Endocrine DiseasesBy Nasdaq OMXNov 17, 2017, 8:01 AM UTC
BusinessArbutus’ LNP Licensee Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for PatisiranBy Nasdaq OMXNov 16, 2017, 6:40 PM UTC
